The enhancer of zeste homolog-2 (EZH2) represses gene transcription through histone H3 lysine-27-trimethylation (H3K27me3). Citrobacter rodentium (CR) promotes crypt hyperplasia and tumorigenesis by aberrantly regulating Wnt/β-catenin signaling. We aimed at investigating EZH2's role in epigenetically regulating Wnt/β-catenin signaling following bacterial infection. NIH:Swiss outbred and Apc Min/+ mice were infected with CR (10 8 CFU); BLT1 −/− Apc Min/+ mice, azoxymethane (AOM)/dextran sodium sulfate (DSS)-treated mice and de-identified human adenocarcinoma samples were the models of colon cancer. Following infection with wild-type but not mutant CR, elevated EZH2 levels in the crypt at days 6 and 12 (peak hyperplasia) coincided with increases in H3K27me3 and β-catenin levels, respectively. Chromatin immunoprecipitation revealed EZH2 and H3K27me3's occupancy on WIF1 (Wnt inhibitory factor 1) promoter resulting in reduced WIF1 mRNA and protein expression. Following EZH2 knockdown via small interfering RNA or EZH2-inhibitor deazaneplanocin A (Dznep) either alone or in combination with histone deacetylase inhibitor suberoylanilide hydroxamic acid, WIF1 promoter activity increased significantly while the overexpression of EZH2 attenuated WIF1 reporter activity. Ectopic overexpression of SET domain mutant (F681Y) almost completely rescued WIF1 reporter activity and partially rescued WIF1 protein levels, whereas H3K27me3 levels were significantly attenuated suggesting that an intact methyltransferases activity is required for EZH2-dependent effects. Interestingly, although β-catenin levels were lower in EZH2-knocked down cells, F681Y mutants exhibited only partial reduction in β-catenin levels. Besides EZH2, increases in miR-203 expression in the crypts at days 6 and 12 post infection correlated with reduced levels of its target WIF1; overexpression of miR-203 in primary colonocytes decreased WIF1 mRNA and protein levels. Elevated levels of EZH2 and β-catenin with concomitant decrease in WIF1 expression in the polyps of CR-infected Apc Min/+ mice paralleled changes recorded in BLT1 −/− Apc Min/+ , AOM/DSS and human adenocarcinomas. Thus, EZH2-induced downregulation of WIF1 expression may partially regulate Wnt/β-catenin-dependent crypt hyperplasia in response to CR infection.
INTRODUCTION
Enhancer of zeste homolog-2 (EZH2) is the catalytic component of PRC2 that catalyzes trimethylation of its substrate H3K27, which is usually associated with transcriptional silencing. Adult tissues generally lack EZH2 expression. However, higher proliferative index is commonly associated with EZH2 overexpression in cancer. Indeed, loss of EZH2 inhibits growth of cancer cells, induces senescence and apoptosis, and decreases invasion and metastasis. [1] [2] [3] EZH2 overexpression and tumor invasiveness or metastasis has been corroborated by the suppressing function of EZH2 on the expression of several microRNAs (miRNAs) that regulate PRC1, KLF2, epithelial-mesenchymal transitionsuppressor E-cadherin, [4] [5] [6] [7] whereas EZH2 itself is regulated by miRNAs like miR-26a and miR-101. 8 Wnt/β-catenin signaling has important roles during normal cellular development. Aberrant activation of Wnt/β-catenin is associated with various human diseases including cancer. 9 Lossof-function mutations in Apc gene (encoding APC) and gain-offunction mutation in CTNNB1 (encoding β-catenin) have been suggested as the chronic preferred route for Wnt-signaling deregulation in cancer. But abnormal accumulation of β-catenin does not always correlate with mutational activation as was evident in hepatocellular carcinoma 10 suggesting that epigenetic mechanism may work in tandem with genetic changes to modulate the process of Wnt/β-catenin-induced cellular transformation and tumorigenesis.
Citrobacter rodentium (CR)-induced transmissible murine colonic hyperplasia that utilizes a type-three secretion system to activate Wnt/β-catenin signaling represents the earliest molecular and functional changes associated with colon carcinogenesis. Employing this model, we showed previously that increases in β-catenin that correlates with colonic crypt hyperplasia are neither due to mutations in Apc or CTNNB1 gene. [11] [12] [13] [14] [15] [16] More recently, we showed that distinct changes in the expression of histone deacetylases (HDACs), histone methyltransferases, SMYD3 and EZH2, and in their substrates H3K4me3 and H3 lysine-27-trimethylation (H3K27me3), respectively, were associated with crypt hyperplasia and epithelial-mesenchymal transition. 16 EZH2 also interacts with HDACs in transcriptional silencing to promote loss of tumor suppressor function, whereas the overexpression of EZH2 is a marker of advanced and metastatic disease in many solid tumors, including colon cancer. Yet, how EZH2 regulates β-catenindependent Wnt signaling within the colonic crypts and whether EZH2/β-catenin-mediated downregulation of Wnt antagonists (for example, Wnt inhibitory factor 1 (WIF1) has a role in CR-induced crypt hyperplasia and tumorigenesis, is not known. Similarly, miRNAs are short (~22 bp length) noncoding RNAs that regulate gene expression post-transcriptionally by binding to the 3′-UTR region of the target genes thereby either destabilizing mRNA or inhibiting translation. Yet, how miRNAs are involved in regulating the components of Wnt signaling in vivo is less understood. We therefore hypothesized that CR infection-induced epigenetic remodeling may underlie Wnt/β-catenin-dependent crypt hyperplasia and tumorigenesis. This hypothesis was tested in the current study.
RESULTS

Effect of CR infection on the expression of PcG protein EZH2
In a recent study, we showed significant alterations in the expression of HDACs, histone methyltransferases SMYD3 and EZH2 and in their substrates H3K4me3 and H3K27me3, respectively, in the colonic crypts in response to CR infection. 16 Modulation of host transcription by pathogens is well accepted; yet, how specific epigenetic programs are controlled by pathogens is not known. EZH2 is overexpressed in several malignancies including colon cancer; EZH2's role in tumor initiation, however, is less clear. During immunostaining with anti-EZH2, distal colonic sections from uninfected control mice exhibited nuclear staining predominantly at the base of the crypt. At day 6 and particularly at day 12, intense nuclear staining extending throughout the longitudinal crypt axis was recorded (Figure 1a) . At days 20, 27 and 34, a downward trend of EZH2 immunoreactivity was observed ( Figure 1a ). To determine whether these changes are specifically induced by CR or whether they are normal host responses to CR infection, we infected NIH:Swiss outbred mice with wild-type CR or ΔescV type-three secretion system mutant, which fails to inject CR's effector proteins into the host. 17 In response to wild-type CR, we observed a predictable crypt hyperplasia at 12 days post infection as was evident following PCNA staining, whereas no such increase was recorded with ΔescV ( Figure 1b) . Interestingly, EZH2 exhibited dramatic colocalization with PCNA in response to wild-type CR at day 12, whereas the extent of colocalization with ΔescV paralleled that of uninfected control (Figure 1b) . Western blot analyses showed wild-type CR-induced increases in EZH2, H3K27me3, β-catenin, SMYD3 and HDAC1, whereas ΔescV mutant exhibited an attenuated response ( Figure 1c) . Thus, increases in crypt EZH2, H3K27me3, β-catenin and so on, are specific to infection by wild-type CR and correlate with levels recorded during advanced carcinomas. 18, 19 For functional assays in vitro, we chose human embryonic kidney HEK-293T cells that offer better transfection efficiency. In HEK-293T cells, CR infection induced significant increases in EZH2's mRNA expression (Supplementary Figure 1Ai) . Knockdown of EZH2 confirmed either at the mRNA or protein level ( Supplementary Figures 1Aii and B) was associated with significant decrease in β-catenin abundance suggesting EZH2's involvement in Wnt signaling. Next we performed wound healing and spheroid assays to determine if EZH2 was functionally relevant. Following the knockdown of EZH2 via specific small interfering RNA (siRNA), cell migration was significantly inhibited when compared with cells treated with control siRNA (Supplementary Figure 1C) . This is consistent with EZH2's role as a promoter of metastasis and malignancy. 20 Recent studies have also implicated EZH2 in the maintenance of stem cells. 20 As the ability to self-renewal is a hallmark of stem cells, and the formation of epithelial-like colonies (spheroids) is an index of self-renewal, 21 we performed spheroid assay in either HEK-293T or HCT116 cells, respectively. EZH2 depletion dramatically reduced the size and number of spheroids in either cell lines (Supplementary Figure 1D) indicating that EZH2 is required for stem cell maintenance. Indeed, real-time reverse transcription (RT)-PCR for cancer stem cell markers revealed significant reduction in CD44 and Dclk1expression following EZH2 knockdown, whereas expression of Lgr5 was less affected in HEK-293T cells (Supplementary Figures 1E and G) . Interestingly, EZH2 knockdown in HCT116 cells had more pronounced effect on downregulation of these cancer stem cell markers (Supplementary Figure 2) . Thus, EZH2 is efficiently induced in the colonic crypts in response to bacterial infection wherein, it mimics conditions reminiscent of advanced stages of colon cancer despite CR infection being a self-limiting disease.
Novel regulation of Wnt antagonist WIF1 by EZH2 We showed recently that EZH2 depletion led to significant decrease in β-catenin/Tcf4-dependent TOP-Flash reporter activity owing to the loss of β-catenin. 16 This finding prompted us to speculate that EZH2 depletion may lead to derepression of Wnt antagonists thereby attenuating Wnt signaling. To examine this, we knocked down EZH2 with specific siRNA and analyzed the expression levels of Wnt antagonists Dkk1, Dkk2, Dkk3, sFRP1, sFRP2, sFRP4 and WIF1 via real-time RT-PCR. Among these genes, only WIF1 transcript exhibited any significant upregulation following EZH2 knockdown (Figures 2a and ci) . This result was also confirmed at the protein level by western blotting the total extracts (Supplementary Figure 3A) . These changes in the expression of Wnt antagonists were also compared with ΔescV mutant and as depicted in Supplementary Figures 3Bi-Ciii, except for sFRP2, the expression levels returned to baseline with mutant CR. To replicate these changes in primary cells, we utilized immortalized young adult mouse colon cells wherein, CR infection induced significant increases in EZH2 expression both at 24 and 72 h, whereas WIF1 expression was likewise downregulated at these time points (Supplementary Figures 3Di and ii) . Interestingly, infection with CR-mutant ΔescV attenuated either increase in EZH2 or decrease in WIF1 expression ( Supplementary  Figures 3Ei and ii) . Finally, the overexpression of EZH2 in young adult mouse colon cells, confirmed at the mRNA level (Supplementary Figure 3Fi) was associated with significant decrease in WIF1 expression (Supplementary Figure 3Fii) . Next we performed WIF1 expression analysis in the isolated crypts. As depicted in Figure 2cii , WIF1 expression was high in uninfected crypts. At days 6 and 12, significant attenuation of WIF1 expression was recorded. Interestingly, WIF1 expression returned to baseline at day 34 ( Figure 2cii ) consistent with regressing phase of crypt hyperplasia. 22 During immunohistochemistry, we observed dramatic decreases in crypt WIF1 immunoreactivity at days 6-20 compared with uninfected control (Figure 2d ). At days 27 and 34, we observed significant rebound in WIF1 staining in the crypt regions, whereas stromal staining was consistent with WIF1 being a secretory protein (Figure 2d ). Figure 2e is the line plot demonstrating reciprocal relationship between EZH2 and WIF1. This reciprocal relationship between EZH2 and WIF1 was further validated in a series of distal colonic sections from Wither NIH: Swiss outbred mice or Apc Min/+ mice wherein, colocalization studies revealed EZH2 staining in only those areas that were negative for WIF1 and vice-versa (Supplementary Figure 4) . Thus, a reciprocal relationship between EZH2 and WIF1 wherein, high EZH2 levels (mRNA or protein) coincident with progression of hyperplasia preceded elevated accumulation of WIF1 when the crypt hyperplasia was regressing. 22 Transcriptional repression of WIF1 by EZH2's recruitment to WIF1 promoter Next, we set out to understand whether the reciprocal relationship between EZH2 and WIF1 could be a result of a direct effect of EZH2 on the WIF1 promoter. We performed quantitative chromatin immunoprecipitation (qChIP) in day 6 crypt DNA samples for the minimal promoter of WIF1 using antibodies against EZH2 and H3K27me3 proteins, respectively.
Supplementary Figure 5 depicts the sequence of the mouse WIF1 promoter. A 1.66-kb fragment amplified using mouse genomic DNA as a template was sequenced with primers shown in boxes. The sequence was obtained from the mouse genome sequence database at the UCSF web server (http://genome.ucsf.edu) using the promoter search program (http://gpminer.mbc.nctu.edu.tw). Figure 3a represents the regions in the mouse WIF1 promoter, located at chromosome 10, that were analyzed via qChIP. As depicted in Figure 3bi and bii, the qChIP analyses exhibited an enriched presence of EZH2 and H3K27me3 on the WIF1 promoter relative to uninfected control. Intriguingly, the promoter region with maximum binding to EZH2 was observed to be distal to the region where maximum H3K27me3 modification occurred suggesting that EZH2's role in either WIF1 downregulation or β-catenin upregulation, may be independent of its methyltransferase activity. This is not unprecedented as Jung HY et al. 23 recently demonstrated that PAF (PCNA-associated factor) recruits EZH2 to the β-catenin transcriptional complex and specifically enhances Wnt signaling independently of EZH2's methyltransferase activity. To begin to unravel the mystery of EZH2 and H3K27me3's regulation of WIF1 promoter, we adopted two different strategies. First, we cloned a 1.66 kb regulatory region of mouse WIF1 containing the EZH2-binding regions ( Figure 3a ) to a pGL3 luciferase reporter construct for promoter assay. During measurement of mouse WIF1 promoter activity in HEK-293T cells, the knockdown of EZH2 with specific siRNAs significantly increased ΔescV mutant-infected mouse distal colons were co-stained with antibodies for EZH2 and PCNA (a marker of proliferation). DAPI was used to label nuclei. Scale bar = 100 μm (n = 3 independent experiments). (c) Nuclear protein extracts prepared from the colonic crypts of mice described in b were subjected to western blotting with antibodies specific to indicated proteins. Crypt cells were isolated from uninfected normal or day 6 post infected distal colons. A ChIP assay was performed with antibodies specific to EZH2 (bi) and H3K27me3 (bii), respectively. The DNA purified after ChIP was evaluated by semiquantitative PCR using primers specific for regions of WIF1 promoter described in a. The bar graphs represent the fold enrichment relative to input (n = 3 independent experiments). (c) Effect of EZH2 knockdown on WIF1 promoter activity. HEK-293T cells were transfected with WIF1-Luc reporter vector for 24 h followed by depletion of EZH2 with either specific siRNAs (ci) or treatment with deazaneplanocin A and suberoylanilide hydroxamic acid either alone or in combination for another 24 h (cii) followed by measurement of reporter activity (*Po 0.05; n = 5 independent experiments). di-dii. Methyltransferase function is required for WIF1 regulation. (di) Measurement of WIF1 promoter activity following EZH2 knockdown or overexpression of either wild type or F681Y mutant (* and **Po 0.05; n = 3 independent experiments).
(dii) Group of cells described in di were western blotted for indicated proteins (n = 3 independent experiments). (e) WIF1 regulates Wnt signaling. HEK-293T cells transfected with TOPflash reporter were either treated with GSK-3β inhibitor for 24 h or transiently co-transfected with EZH2 or WIF1 cDNAs followed by measurement of reporter activity (*P o0.001 vs control; n = 3 independent experiments).
WIF1 reporter activity ( Figure 3ci ). As HDAC activity is associated with transcriptional repression 7, 18 and based on significant upregulation of HDACs in the colonic crypts in response to CR infection, 16 we next examined if HDACs could be part of the repressive complex that catalyzed the transcriptional repression of WIF1. Indeed, treatment with HDAC inhibitor suberoylanilide hydroxamic acid (SAHA) either alone or in combination with deazaneplanocin A reversed EZH2-mediated repression of the WIF1 promoter activity (Figure 3cii ), indicating that HDAC activity is complementary to EZH2-mediated WIF1 suppression. Second, we mutated the tyrosine-681 in the catalytic domain of EZH2 that regulates its enzymatic activity. 24 Ectopic overexpression of F681Y mutant almost completely rescued WIF1 reporter activity and partially rescued WIF1 protein levels while H3K27me3 levels were completely attenuated (Figure 3di and ii) suggesting that an intact methyltransferase activity is required for EZH2-dependent effects. Interestingly, although β-catenin levels were lower in EZH2-knocked down cells, F681Y mutant exhibited only partial reduction in β-catenin levels (Figures 3di and ii) . To establish a direct role for WIF1 in downregulating Wnt signaling, we overexpressed both EZH2 and WIF1 in HEK-293T cells and measured TopFlash reporter activity. As depicted in Figure 3e , EZH2 overexpression significantly increased the TopFlash activity as expected, whereas the overexpression of WIF1 resulted in almost complete attenuation of TopFlash activity suggesting antagonism of WIF1-induced Wnt signaling.
Next in a series of experiments to further validate the reciprocal relationship between EZH2 and WIF1, we performed reporter assays with human promoter for WIF1 to see if EZH2 is also involved in WIF1 repression in humans. Knockdown of EZH2 significantly increased, whereas the overexpression of EZH2 resulted in decrease in WIF1 reporter activity ( Supplementary  Figures 6A and B) . Both deazaneplanocin A and suberoylanilide hydroxamic acid either alone or in combination reversed the inhibitory effects (Supplementary Figure 6C) . In addition, we utilized another known HDAC inhibitor, sodium butyrate (NaB) 25 to further assess the effect of HDAC inhibition on WIF1 mRNA. As expected, NaB significantly blocked CR-induced increases in EZH2 and H3K27me3 both at the mRNA and protein level (Supplementary Figures 6D and E) while concomitantly increasing WIF1 mRNA levels by 10-fold (Supplementary Figure 6F) . Finally, during WIF1 reporter assay in HCT116 human colon cancer cell line, knockdown of EZH2 likewise increased the WIF1 reporter activity, whereas treatment with deazaneplanocin A or suberoylanilide hydroxamic acid either alone or in combination yielded results ( Supplementary Figures 6G and H ) similar to those recorded in HEK-293T cells. Collectively, these data suggest that EZH2 in cooperation with HDACs, transcriptionally repress WIF1 probably via histone methylation and deacetylation.
MicroRNA regulation of WIF1 transcription As miRNAs are components of epigenetic regulation, we set out to assess the contribution of miRNAs in mouse colonic hyperplasia. Total crypt RNA isolated from uninfected normal or days 6-34 post-CR infected distal colons was subjected to a miRNA array. As depicted in Figure 4a , a heat map was generated showing the differential expression intensities of indicated miRNAs. Among the most upregulated ones, miR-7a, miR-17, miR-20a, miR-21, miR-142-3p and miR-203 were further validated via real-time RT-PCR (Figures 4bi-vi) . Of these miRNAs, we were particularly interested in miR-203 owing to its involvement in Wnt signaling and epithelial-mesenchymal transition. 21 To identify the targets of miR-203, we used miRNA target analysis (www.targetscan.org) and found a number of putative target genes such as Dkk1, Nkd1, WIF1, sFRP1, APC, KL4, NLK and TCF4 that are associated with Wnt signaling. We selected WIF1 as one of the targets of miR-203 for several reasons. We wanted to explore whether: (a) CR-induced changes in either miR-203 or EZH2 mimic what happens during the late stages of colon carcinogenesis and (b) whether WIF1 that exhibited the greatest change in its expression following EZH2 knockdown (see Figure 2ci) , could be the bridging molecule to link both miR-203 and EZH2 to Wnt signaling. The predicted binding site of miR-203 in the 3′-UTR sequence of WIF1 (Figure 4c ) was cloned downstream of the firefly luciferase gene in the pGL4-NF-κB-Luc vector. When the cells were co-transfected with miR-203 and pGL4-NF-κB-Luc 3′-UTR-WT, there was a significant reduction in luciferase activity compared with cells transfected with the control vector (Figure 4di ). In addition, HEK-293T cells stably expressing miR-203 when co-transfected with the above construct exhibited significant decrease in luciferase activity, whereas the overexpression of miR-21 had no effect on reporter activity (Figure 4dii ). To further validate miR-203's dependence on 3′-UTR to block WIF1 function, we mutated the 3′-UTR site and following transfection into HEK-293T cells, compared the reporter activity with the wild-type counterpart. Indeed, cells expressing wild-type 3′-UTR exhibited significant decrease in reporter activity in response to miR-203 overexpression, whereas a construct, pGL4-NF-κB-Luc-3′UTR-mut, expressing mutated 3′-UTR failed to exhibit any change in the luciferase activity (Figure 4diii) . Finally, in a twopronged approach, overexpression of miR-203 but not miR-21 or miR-142-3p reduced the WIF1 mRNA (Figure 4e ) as well as protein levels (Figure 4f ). Thus, we provide evidence for epigenetic regulation of Wnt antagonist WIF1 by EZH2 and miR-203.
EZH2 expression negatively correlates with WIF1 levels and positively with β-catenin accumulation in mouse and human adenoma/adenocarcinoma To validate the inverse association between EZH2 and WIF1, we examined the staining intensities of EZH2 and WIF1 in four different models of colon cancer. We 26, 27 and others 28 have shown that Apc Min/+ mice when infected with CR exhibit exaggerated tumorigenesis in the distal colon, the site of CR infection. As depicted in Figure 5a , EZH2 staining in the uninfected control mice was mostly restricted to the basal 1/3rd of the crypt. Following CR infection, the entire adenoma developed in the distal colon at 12 weeks exhibited intense EZH2 staining that correlated with similar increases in β-catenin staining compared with uninfected control (Figure 5a ). WIF1 staining on the other hand, was significantly higher in the uninfected control, whereas a dramatic loss of WIF1 staining was associated with CR-induced increases in colonic tumors in these mice (Figure 5a ). These changes are usually associated with adenocarcinomas in humans and poor prognosis 18, 19 suggesting that CR infection mimics human conditions despite being a self-limiting disease.
Leukotriene B4-induced signaling pathway that mediates its actions via high-affinity G protein-coupled receptor BLT1, is implicated in human colon cancer. 29 We have developed a novel model of spontaneous intestinal cancer by crossing the BLT1 
Apc
Min/+ mice as a model for spontaneous colon tumorigenesis, we observed no detectable EZH2 staining in BLT1 −/− control mice, whereas a dramatic increase in EZH2 staining encompassing the entire adenoma was recorded in the BLT1
−/−
Apc
Min/+ mice at 110 days that correlated positively with increases in β-catenin nuclear staining (Figure 5b ) and coincided with the dramatic decrease in WIF1 staining compared with BLT1 −/− mice alone (Figure 5b ). These findings were further validated in a murine model of colitis-associated colon cancer wherein, adenoma was initiated with azoxymethane (AOM) treatment followed by dextran sodium sulfate (DSS) ingestion in ICR outbred mice. As depicted in Figure 5c , increases in EZH2 and its substrate, H3K27me3 and β-catenin immunostaining in the distal colons of AOM/DSS-treated mice coincided with dramatic loss of WIF1 staining compared with either untreated (Figure 5c ) or AOM or DSS-treated mice (data not shown), respectively. During analysis of human adenocarcinoma or adenocarcinoma with an invasive front, adjacent mucosa exhibited EZH2 nuclear staining mostly at the base of the crypt (Figure 6a ). In adenocarcinomas, the entire longitudinal crypt axis as well as the invasive front exhibited intense nuclear staining for EZH2 (Figure 6a) . Similarly, we observed mostly membranous staining for β-catenin in the adjacent mucosa, whereas staining was intense and predominantly nuclear in the adenocarcinomas (Figure 6a ). In contrast, WIF1 staining, although intense in the adjacent mucosa, was almost non-detectable in the areas of adenocarcinomas that were positive for EZH2 (Figure 6b ). 
DISCUSSION
Bacterial pathogens promote histone modifications and chromatin remodeling as an important strategy to interfere with key cellular processes in the infected cells. 30 We recently showed that CR infection induced significant alterations in epigenetic signaling in the distal colon that coincided with Wnt/β-catenin, Notch and NF-κB-dependent increases in colonic crypt hyperplasia. [11] [12] [13] [14] [15] [16] 31 In the current study, we describe a novel mechanism by which Wnt antagonist WIF1 is downregulated in EZH2-overexpressing cells through histone H3K27 trimethylation at the WIF1 promoter, which may be directly involved in epigenetic upregulation of β-catenin function in response to CR infection. Although these findings are consistent with either targeted overexpression of EZH2 in the mammary gland that causes epithelial hyperplasia 32 or in response to Helicobacter pylori CagA-mediated aberrant epigenetic silencing that induces Ras upregulation, 33 CR-induced EZH2 upregulation in a non-transformed colonic epithelium mimics advanced stages of colon carcinogenesis despite transmissible murine colonic hyperplasia being a self-limiting disease. 34 We have further discovered that blocking EZH2 function in vitro inhibited cell migration and spheroid growth owing to decreases in cancer stem cell markers CD44, Dclk1 and Lgr5. This is consistent with EZH2's role in self-renewal, pluripotency and proliferation of cancer stem cells. 35 Interestingly, elevated EZH2 expression resulted in increased accumulation of EZH2 itself along with its target H3K27me3 on the WIF1 promoter, which led to significant downregulation of WIF1 expression (see Figure 3) . Wnt antagonists are natural inhibitors of Wnt/β-catenin signaling that work in different subcellular compartments in the cell. Epigenetic Sections were stained with antibodies for: EZH2, β-catenin and WIF1 (original magnification = × 200; n = 2 independent experiments). A total of 18 de-identified adenoma/adenocarcinoma samples and the corresponding controls were analyzed for EZH2 and WIF1 staining. Significant inverse correlation between EZH2 and WIF1 labeling were recorded that paralleled the staining pattern observed with mouse models of colon cancer.
silencing of these inhibitors allows constitutive Wnt/β-catenin signaling in various cancers. 10, 36 Inactivation of Wnt antagonist WIF1, mostly through DNA hypermethylation of the promoter region has been reported as an early event in various cancers even though fewer studies suggest a correlation between loss of WIF1 expression and disease progression. 37 On the other hand, a recent study by Kondo et al., 2 suggested that gene silencing by histone H3K27 trimethylation was independent of the WIF1 promoter methylation. Our findings support this notion that EZH2 and its target, H3K27me3's accumulation on the WIF1 promoter, at least in part, silences its expression. Intriguingly, ChIP assays also revealed discrepancy between EZH2 and H3K27me3 amplicons suggesting the notion that EZH2's regulation of Wnt/β-catenin signaling may be uncoupled with its methyltransferase function. Studies with catalytic domain mutant F681Y of EZH2 24 revealed significant recovery of WIF1 reporter activity, whereas H3K27me3 levels were completely attenuated, which to some extent ruled out the possibility that EZH2's methyltransferase function is irrelevant to its epigenetic regulation of WIF1 expression. Whether WIF1 demethylation is responsible for this reversal in WIF1 function following point mutation in EZH2, however, remains to be delineated. Interestingly, F681Y mutant exhibited only partial reduction in β-catenin levels suggesting that point mutations in EZH2 may not be sufficient by themselves to block Wnt signaling, and that residual endogenous EZH2 may be enough to promote Wnt/β-catenin signaling. Nonetheless, a direct role for WIF1 in downregulating Wnt signaling was revealed by WIF1 overexpression that resulted in almost complete attenuation of TopFlash activity. It is also worth mentioning that EZH2 also interacts with HDACs in transcriptional silencing to promote loss of tumor suppressor function. Indeed, HDACs seem to be an important component of the EZH2-mediated WIF1 repression in our model, as cells treated with HDAC inhibitor NaB reversed the suppressive activity of EZH2 on the WIF1 promoter suggesting that EZH2 catalytic activity or EZH2-mediated H3K27me3 accumulation on the WIF1 promoter alone may not be sufficient for promoter silencing; rather repressing enzymes including HDACs may be necessary for further chromatin condensation and transcriptional repression. This is consistent with our previous report wherein, HDAC1-4 upregulation observed during CR-induced colonic crypt hyperplasia 16 may corroborate with EZH2 to promote epigenetic silencing of WIF1 18 thereby at least partially regulating Wnt/β-catenin signaling.
We also delineated another mechanism of WIF1 transcriptional regulation by miRNA. Following a microarray analysis, miR-203 along with several other miRNAs was upregulated several fold in the colonic crypts of CR-infected mice (see Figure 4) . Database search of miR-203 revealed several putative target genes related to Wnt/β-catenin signaling pathway including WIF1. In the current study, we provide evidence that WIF1 was regulated by miR-203 suggesting that miR-203 may corroborate with EZH2 to repress WIF1 expression in response to CR infection. This is consistent with a recent report wherein, CagA was shown to induce aberrant epigenetic silencing of let-7 expression leading to Ras upregulation during H. pylori-related gastric carcinogenesis 33 suggesting that infection-induced deregulation of epigenetics and miRNA expression may be a novel potential target for the prevention of gastric or colon carcinogenesis, respectively.
We have employed an animal model (transmissible murine colonic hyperplasia) that involves the earliest molecular and functional changes associated with colon carcinogenesis. However, if transmissible murine colonic hyperplasia is a unique response to a peculiar bacterium, it may not be of general interest. To rule out this possibility, we examined mice that either develop spontaneous colon cancer (BLT1 −/−
Apc
Min/+ ) as well as mice that developed colon cancer in response to mutagenic and inflammatory insults. Finally, we also capitalized on the availability of human adenocarcinomas from our biospecimen repository to establish the relevance of our studies to humans. During a thorough and systematic analysis, we discovered that changes recorded in EZH2 and β-catenin expression in the distal colons of either BLT1 −/− Apc Min/+ mice or AOM/DSS-treated mice were mirror images of those recorded during CR infection. Similarly, human adenocarcinomas with and without invasive front, exhibited aberrant EZH2 and β-catenin nuclear staining that paralleled changes recorded during CR infection. The increases in EZH2 and β-catenin staining in either murine or human tissues were associated with concomitant decreases in WIF1 staining suggesting a tumor suppressing function of WIF1 that may have been epigenetically repressed to promote Wnt signaling. These findings are consistent with EZH2's role in silencing several anti-metastatic genes (for example, E-cadherin) to promote cell invasion and anchorage-independent growth. 38 Thus, the epigenetic signaling pattern in the CR model is not unique but shares a common final pathway with seemingly diverse models of colonic crypt proliferation and carcinogenesis and that the findings in the CR model may very well have broader pathophysiologic and clinical significance. Apc Min/+ mice were developed in the laboratory of Dr Bodduluri Haribabu, Professor, University of Louisville, and bred at KU Medical Center. For AOM/DSS model following intraperitoneal pretreatment with AOM (10 mg/kg body weight), the animals were subjected to three cycles of alternating administration of 2.5% DSS for 7 days followed by distilled water for the subsequent 14 days. Mice were killed at 24 weeks. Colonic crypts were isolated as described. [11] [12] [13] [14] [15] [16] 22, 26, 31 De-identified and paraffin-embedded human adenocarcinoma sections were kindly provided by University of Kansas Cancer Center Biospecimen Repository Core.
MATERIALS AND METHODS
Cell lines and plasmids
Unless mentioned otherwise, all cell lines were obtained from American Type Culture Collection (Rockville, MD, USA). All cells were grown in 5% CO 2 , Dulbecco's modified Eagle medium or Roswell Park Memorial Institute medium containing 10% fetal bovine serum and penicillin/streptomycin. Young adult mouse colon were cultured as described elsewhere. 16 All plasmid constructs sequences were verified by automated DNA sequencing. Drug selection on pEZX-miRNAs (GeneCopoeia, Rockville, MD, USA) transduced cells was carried out in puromycin (1.0 μg/ml; Sigma-Aldrich, St Louis, MO, USA). Control, containing a scrambled sequences, transduction was carried out in parallel. All the transduced cells were subsequently cultured in media containing 1.0 μg/ml puromycin (Sigma).
Western blot analysis
Total crypt cellular or nuclear extracts were prepared as described. 15 Cell lysates, from cell lines, were prepared in RIPA (radioimmunoprecipitation assay) buffer with complete protease inhibitors (Roche Applied Science, Indianapolis, IN, USA). Western blots were performed as described before.
cDNA reverse transcription kit (Applied Biosystems, Foster City, CA, USA). cDNAs were used for real-time PCR using Jumpstart Taq DNA polymerase (Sigma-Aldrich) and SYBR Green (Molecular Probes, Eugene, OR, USA) nucleic acid stain as a marker for DNA amplification on a Bio-Rad CFX96 Touch Real-Time PCR Detection System (Bio-Rad, Hercules, CA, USA). Relative fold change values were calculated with the comparative threshold cycle (ΔCt) method normalized to glyceraldehyde-3-phosphate dehydrogenase. Changes in mRNA expression were expressed as fold change relative to control. Primer sequences for all target genes and internal control are shown in Supplementary Table 1. Chromatin immunoprecipitation (ChIP)
ChIP assays were performed as described. 16 We used the following antibodies in the ChIP study: anti-EZH2, anti-H3K27me3 (Cell Signaling Technology, Danvers, MA, USA). All the experiments in tissue specimens were repeated at least three times. The sequences of the PCR primers are shown in Supplementary Table 2 .
Reporter gene assays Reporter activities were measured as described. 16 Briefly, at 24 h post transfection, cells were infected with CR at multiplicity of infection of 90 for 3 h. Cells were then washed to remove the bacteria and incubated at 37°C with or without drugs for 24 and 48 h. Synergy H4 hybrid microplate reader (BioTek, Winooski, VT, USA) was used to measure the luminescence.
Construction of the human and mouse WIF1 promoter regions and measurement of promoter reporter activities
Reporter vector containing regions of Human WIF1 (−1463 to − 102) promoter (HPRM16566-PG02; GeneCopoeia) was sub cloned in pGL3-Luc basic vector (Promega, Madison, WI, USA). For cloning of mouse WIF1 promoter, we used a PCR-based technique. Sense (5′-TGTCTAACTCCCA AACACAATACC-3′) and anti-sense (5′-TCCGAGCCATGGTGCTCAGGACC-3′) primers were chosen from the genomic sequence of the mouse WIF1 gene (Accession No. AC153357), corresponding to the sequence − 1653 to +10 (the start codon ATG of mouse WIF1 gene is defined as +1). PrimeSTAR GXL PCR (Clontech, Mountain View, CA, USA; 30 cycles) was performed. All the sequences were verified by DNA sequencing (ACGT, Inc., Wheeling, IL, USA). Cells were co-transfected using 1.0 μg of each DNA construct in pGL3Basic vector and 0.05 μg of pRL-TK Vector (Promega) containing Renilla luciferase as an internal control for the transfection efficiency. For co-transfection, siEZH2 or EZH2 expression vectors were transfected simultaneously along with reporter constructs. Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) was used. Reporter activity was measured as above. HEK-293T cells were treated with 1 μM suberoylanilide hydroxamic acid, 2.5 mM of NaB and 2.5 μM deazaneplanocin A or in combination for 40 h followed by Luciferase reporter assay. miRNAs assay and 3′-UTR cloning All miRNAs assay kits were purchased from ABI (Life Technologies, Grand Island, NY, USA). Small nuclear RNA U6 were used as an internal control and relative fold change values were calculated with the comparative threshold cycle (ΔCt) method normalized to U6. The luciferase reporter gene construct containing the miR-203 targeting site from the 3′-UTR of WIF1 or others was created by cloning around 40-bp fragment (positions 1890 to 1930, NM_007191), containing the miRNA-203 binding site into the EcoI site on the 3′-region of the luciferase gene in the pGL4.32 (Luc2P/ NF-κB197 RE/hygro) firefly luciferase reporter vector (Promega). A mutant construct of the above was made the same way. The constructs were sequenced to check the proper orientation or to eliminate any undesired mutation. 293T cells were transfected with either the construct above or (pGL4.15 (luc2p/Hygro) vector) as control (Promega), using Lipofectamine 2000 transfection reagent (Invitrogen). After 24 h of transfection, luciferase activity was measured using a Bright Glo Luciferase assay system (Promega).
Histology and immunohistochemistry
For histology, tissues were fixed in 10% neutral buffered formalin or Carnoy's fixative (60% methanol, 30% chloroform and 10% acetic acid) before paraffin embedding. Images were obtained with an Eclipse E1000 microscope (Nikon Instruments, Melville, NY, USA). Immunohistochemistry to detect EZH2, H3K27me3, (antibodies from Cell Signaling), β-catenin (BD, Biosciences, San Jose, CA, USA) and WIF1 (Santa Cruz Technology, Santa Cruz, CA, USA) was performed on 5-μm-thick paraffin-embedded sections prepared from the distal colons of groups of mice described elsewhere utilizing the horseradish peroxidase-labeled polymer conjugated to secondary antibody using the Histostain-SP Kit (DAB, broad spectrum; Invitrogen) with microwave accentuation, as described previously. 32 Antibody controls included omission of the primary antibody or detection of endogenous IgG staining with goat anti-mouse or anti-rabbit IgG (Calbiochem, San Diego, CA, USA). For statistical analysis of the staining scores, Student's t-test was performed (see Statistical analysis).
Spheroid and wound healing assays and RNA interference Confluent monolayers of cells were trypsinized. Low cell-binding plates were used to seed the cells in corresponding culture medium containing 20 ng/ml of fibroblast growth factor, 20 ng/ml of EGF (Sigma) and 10 ml/ 500 ml of B27 supplement (BD Biosciences) and cultured at 37°C (5% CO 2 , 100% humidity). Multicellular spheroids were designated as random spheroids and used for all experiments that employed larger populations of cells. HEK-293T cells were treated with siRNAs of EZH2 or non-targeting control and grown to confluence on 12-well plastic dishes, wounded by scratching with a sharp pipette tip and washed with fresh media. Wounds were photographed at 0, 12 and 24 h intervals with microscope with a × 10 objective. A portion of the cells treated with siRNAs was taken separately for western blot analysis. The siRNA-targeting EZH2 (Cat# S102665166) and All Star negative control (Cat# 1027280) were purchased from Qiagen (Germantown, MD, USA) and siRNAs targeting EZH2 (SASI_Hs02_00337644 and SASI_Hs01_00147882) were from Sigma. Cells were transfected with 100 nM final concentrations of siRNA duplexes using Lipofectamine 2000 (Invitrogen) following the manufacturer's instructions.
Statistical analysis
All experimental results are expressed as mean values s.e. Statistical analyses of all studies were performed using unpaired, two-tailed Student's t-tests. P-values of 0.05 were considered significant. ABBREVIATIONS AOM, Azoxymethane; DSS, Dextran Sodium Sulfate.
